Dana Investment Advisors, Inc.

Position in TGTX — Tg Therapeutics, Inc.

CIK 1427514 BROOKFIELD, WI

Position in TGTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,308,139

+$847,988 QoQ

Shares Held

42,012

-4.4% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#137

of 426 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

Dana Investment Advisors, Inc. holds $43,128,971 across 12 Biotechnology names. TGTX ranks #4 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	57,520	$18,181,496
2	AXSM	Axsome Therapeutics, Inc.	22,850	$5,592,994
3	REGN	Regeneron Pharmaceuticals, Inc.	7,719	$4,813,105
4	TGTX	Tg Therapeutics, Inc. This page	42,012	$2,308,139
5	VKTX	Viking Therapeutics, Inc.	57,854	$2,256,884
6	MDGL	Madrigal Pharmaceuticals, Inc.	3,677	$1,974,365
7	ZYME	Zymeworks Inc.	71,660	$1,873,192
8	IONS	Ionis Pharmaceuticals Inc	23,272	$1,845,236

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,308,139	42,012	-4.4%	Shares	Sole	2026-08-13
2026-03-31	$1,460,151	43,954	+4.5%	Shares	Sole	2026-05-14
2025-12-31	$1,254,315	42,077	+18.0%	Shares	Sole	2026-02-05
2025-09-30	$1,288,145	35,658	+26.0%	Shares	Sole	2025-11-10
2025-06-30	$1,018,409	28,297	-5.9%	Shares	Sole	2025-08-13
2025-03-31	$1,186,093	30,081	-20.1%	Shares	Sole	2025-05-15
2024-12-31	$1,133,265	37,650	+0.6%	Shares	Sole	2025-02-06
2024-09-30	$875,604	37,435	-0.7%	Shares	Sole	2024-11-13
2024-06-30	$670,380	37,683	-0.6%	Shares	Sole	2024-08-27
2024-03-31	$576,382	37,895	+82.6%	Shares	Sole	2024-05-15
2023-12-31	$354,478	20,754	-63.9%	Shares	Sole	2024-02-07
2023-09-30	$481,193	57,559	+57.1%	Shares	Sole	2023-11-15
2023-06-30	$909,814	36,627	-6.6%	Shares	Sole	2023-08-15
2023-03-31	$589,868	39,220	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.